1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14C
INFORMATION STATEMENT PURSUANT TO SECTION 14(c)
OF THE SECURITIES EXCHANGE ACT OF 1934
Check the appropriate box:
[X] Preliminary Information Statement
[ ] Confidential, for Use of the Commission Only (as permitted by Rule
14c-5(d)(2))
[ ] Definitive Information Statement
IMP, Inc.
-------------------------------------------------------
(Name of Registrant As Specified In Its Charter)
Payment of Filing Fee (Check the appropriate box):
[X] No fee required
[ ] Fee computed on table below per Exchange Act Rules 14c-5(g) and
0-11
(1) Title of each class of securities to which transaction applies:
(2) Aggregate number of securities to which transaction applies:
(3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which
the filing fee is calculated and state how it was determined):
(4) Proposed maximum aggregate value of transaction:
(5) Total fee paid:
[ ] Fee paid previously with preliminary materials.
[ ] Check box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee was
paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.
(1) Amount Previously Paid:
(2) Form, Schedule or Registration Statement No.: Schedule 14C
1
2
(3) Filing Party: IMP, Inc.
(4) Date Filed: August 21, 2001
2
3
IMP, Inc.
2830 North First Street
San Jose, California 95134
August 21, 2001
INFORMATION STATEMENT
This Information Statement is being mailed to the stockholders of IMP,
Inc., a Delaware corporation (the "Company"), commencing on or about
in connection with the previous approval of the corporate action referred to
below by the majority stockholder of the Company. Accordingly, all necessary
corporate approvals in connection with the matters referred to herein have been
obtained, and this Information Statement is furnished solely for the purpose of
informing stockholders, in the manner required under the Securities Exchange Act
of 1934, as amended (the "Exchange Act"), of the corporate action before it
takes effect. The record date for determining stockholders entitled to receive
this Information Statement has been established as the close of business on
. WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND
US A PROXY.
ACTIONS TAKEN
On March 12, 2001, the Board of Directors of the Company approved,
subject to stockholder approval, the Amended and Restated IMP, Inc. 2000 Stock
Option Plan (the "Restated Plan"). Also on March 12, 2001, Teamasia Mauritius, a
Mauritius corporation and the Company's majority stockholder ("Teamasia"),
executed a written consent approving the Restated Plan.
On June 21, 2001, the Board of Directors of the Company approved, subject
to stockholder approval, a Stock Purchase Agreement (the "Stock Purchase
Agreement"), to be entered into by and between the Company and Subba Mok LLC, a
Delaware limited liability company (the "New Investor"). On July 3, 2001,
Teamasia executed a written consent approving the Stock Purchase Agreement.
1
4
On June 21, 2001, the Board of Directors of the Company approved, subject
to stockholder approval, the Restated Certificate of Incorporation of the
Company (the "Restated Certificate"). On July 3, 2001, Teamasia executed a
written consent approving the Restated Certificate.
On each of March 12, 2001 and July 3, 2001, Teamasia held 5,464,408
shares of common stock, par value $0.01 per share (the "Common Stock"), of the
Company, representing approximately 61% of the outstanding Common Stock on each
such date. As a result, each of (i) the Restated Plan, (ii) the Stock Purchase
Agreement and (iii) the Restated Certificate was approved by a majority of the
shares of Common Stock as required by law, and no further votes will be needed.
The written consents executed by Teamasia will take effect 20 days after the
mailing of this information statement.
AMENDED AND RESTATED IMP, INC. 2000 STOCK OPTION PLAN
The IMP, Inc. 2000 Option Plan (the "Original Plan") was adopted by the
Board of Directors on January 7, 2000 and approved by the Company's stockholders
at the Annual Meeting of stockholders held on June 14, 2000. The Restated Plan
is substantially similar to the Original Plan, provided that the number of
shares of Common Stock issuable thereunder has been increased from 1,000,000 to
3,500,000, in each case without giving effect to the 1-for-5 reverse stock split
contemplated by the Restated Certificate. The purpose of the Restated Plan is to
attract and retain the services of key individuals essential to the Company's
long-term growth and success.
The following is a summary of the principal features of the Restated
Plan, together with the applicable tax and accounting implications for the
Company and the participants. Any stockholder of the Company who wishes to
obtain a copy of the actual plan document may do so upon written request to the
Secretary of the Company at the Company's principal executive offices in San
Jose, California.
Structure
The Restated Plan is divided into two separate components: the
Discretionary Option Grant Program and the Automatic Option Grant Program. Under
the Discretionary Option Grant Program, options may be issued to key employees
(including officers and directors) and key consultants in the service of the
Company (or its parent or subsidiary companies) who contribute to the
management, growth and financial success of the Company. Under the Automatic
Option Grant Program, non-employee Board members will receive a series of option
grants over their period of continued service on the Board.
Administration
The Compensation Committee of the Board of Directors administers the
provisions of Discretionary Option Grant Program with respect to all officers
and directors of the Company subject to the short-swing trading restrictions of
the federal securities laws. With respect to all other participants, the
Discretionary Option Grant Program may be administered by either the
Compensation Committee or a committee of one or more Board members appointed by
the Board of Directors or by the entire Board of Directors itself. Currently,
the Compensation Committee administers the Discretionary Option Grant Program
with respect to all participants. The Compensation Committee is referred to in
this summary as the "Plan Administrator" with respect to its administrative
functions under the Discretionary Option Grant Program.
2
5
The Plan Administrator will have full authority to determine the eligible
individuals who are to receive option grants, the time or times when the option
grants are to be made, the number of shares of Common Stock subject to each such
grant, the date or dates on which the option is to become exercisable, and the
maximum term for which the option is to be outstanding. The Plan Administrator
will also have the discretion to determine whether the granted option is to be
an incentive stock option under the Federal tax laws or a nonstatutory option.
In addition, the Plan Administrator will have full authority to accelerate the
exercisability of one or more outstanding options at any time upon such terms
and conditions as it deems appropriate.
Option grants under the Automatic Option Grant Program will be made in
strict compliance with the express provisions of that program, and the Plan
Administrator will not have any discretionary authority with respect to those
option grants.
Share Reserve
A total of 3,500,000 shares of Common Stock, without giving effect to
the 1-for-5 reverse stock split contemplated by the Restated Certificate,
have been reserved for issuance over the term of the Restated Plan. In no event
may any one participant in the Restated Plan be granted stock options or
separately exercisable stock appreciation rights for more than 1,000,000 shares
in the aggregate, without giving effect to the 1-for-5 reverse stock split
contemplated by the Restated Certificate.
Should an option expire or terminate for any reason prior to exercise in
full, the shares subject to the portion of the option not so exercised will be
available for subsequent issuance under the Restated Plan. Shares subject to any
option surrendered in accordance with the stock appreciation right provisions of
the Restated Plan will not be available for subsequent issuance.
Eligibility
Officers and other key employees of the Company and its parent or
subsidiary corporations (whether now existing or subsequently established), key
consultants in the service of the Company or such parent or subsidiary
corporations and non-employee Board members (other than those serving on the
Compensation Committee) will be eligible to participate in the Discretionary
Option Grant and Stock Issuance Programs. Non-employee Board members (including
those serving on the Compensation Committee) will also participate in the
Automatic Option Grant Program.
Price and Exercisability
The exercise price of shares issued under the Discretionary Option Grant
Program may not be less than 85% of the fair market value per share of Common
Stock on the grant date, and no option may be outstanding for more than a
10-year term. If the granted option is intended to be an incentive stock option
under the Federal tax laws, the option price must not be less than 100% of the
fair market value per share of Common Stock on the grant date. Options issued
under the Discretionary Option Grant Program generally become exercisable in a
series of installments over the optionee's period of service with the Company.
3
6
The option price is payable in cash or in shares of Common Stock.
Outstanding options may also be exercised through a cashless exercise procedure
pursuant to which a designated brokerage firm is to effect an immediate sale of
the shares purchased under the option and pay over to the Company, out of the
sales proceeds available on the settlement date, sufficient funds to cover the
option price for the purchased shares plus all applicable withholding taxes. The
Plan Administrator may also assist any optionee (including an officer) in the
exercise of outstanding options under the Discretionary Option Grant Program by
authorizing a loan from the Company or permitting the optionee to pay the option
price in installments over a period of years.
No optionee is to have any stockholder rights with respect to the option
shares until such optionee has exercised the option, paid the option price for
the purchased shares and been issued a stock certificate for those shares.
Options are not assignable or transferable other than by will or the laws of
inheritance following the optionee's death and, during the optionee's lifetime,
the option may be exercised only by the optionee.
Valuation
For purposes of establishing the option price and for all other valuation
purposes under the Restated Plan, the fair market value per share of Common
Stock on any relevant date will not be less than the closing selling price per
share on such date on the Nasdaq Small Cap Market. On August 14, 2001, the fair
market value per share of Common Stock was $0.25 on the basis of the closing
selling price on that date.
Termination of Service
All options granted under the Discretionary Option Grant Program must be
exercised within twelve months (or such shorter period as the Plan Administrator
may establish at the time of grant) after the optionee ceases for any reason to
be in the employ or service of the Company or its parent or subsidiary
corporations.
4
7
Corporate Transaction
Each outstanding option under the Discretionary Option Grant
Program will become immediately exercisable for all of the shares of Common
Stock subject to such option in the event of a Corporate Transaction (as defined
below), unless (i) that option is assumed by the successor corporation (or its
parent corporation) or replaced with a comparable option to purchase shares of
stock of the successor corporation (or its parent corporation) or (ii) the
acceleration of such option is precluded by other limitations imposed by the
Plan Administrator at the time of grant. A Corporate Transaction includes one or
more of the following transactions:
a. a merger or acquisition in which the Company is not the surviving
entity, except for a transaction the principal purpose of which is
to change the State of the Company's incorporation;
b. the sale, transfer or other disposition of all or substantially
all of the assets of the Company; or
c. any reverse merger in which the Company is the surviving entity,
but in which fifty percent (50%) or more of the Company's
outstanding voting stock is transferred to holders different from
those who held the stock immediately prior to such merger.
Immediately following the consummation of the Corporate Transaction, all
outstanding options will terminate, except to the extent assumed by the
successor corporation (or its parent company).
5
8
Cancellation and New Grant of Options
The Plan Administrator has the authority to effect, at any time and from
time to time, with the consent of the affected optionees, the cancellation of
any or all options outstanding under the Discretionary Option Grant Program and
to grant in substitution therefor new options covering the same or different
numbers of shares of Common Stock but having an exercise price per share not
less than 85% of the fair market value per share of Common Stock on the new
grant date (or 100% of fair market value if the new option is to be an incentive
stock option).
Automatic Option Grant Program
Under the Automatic Option Grant Program, option grants will be made to
current or future non-employee Board members. Each option grant under the
Automatic Option Grant Program is subject to the following terms and conditions:
- The option price per share will be equal to 100% of the fair
market value per share of Common Stock on the automatic grant
date, and each option is to have a maximum term of ten years
measured from the grant date.
6
9
- Each automatic option grant will become exercisable for the option
shares six months after the grant date, provided the optionee
continues as a member of the Board.
- Shares purchased under the automatic option grant will be subject
to repurchase by the Company, at the option price paid per share,
in the event the optionee should cease to be a Board member prior
to vesting in those shares. The option shares will vest in a
series of over the optionee's period of Board service as follows:
25% of the option shares will vest upon optionee's completion of
one year of Board service measured from the automatic grant date,
and the balance of the option shares will vest in a series of 36
successive equal monthly installments upon the optionee's
completion of each month of Board service thereafter. Full and
immediate vesting of the option shares will occur upon the
optionee's death or disability while a Board member.
- Each automatic option will remain exercisable for a six-month
period following the optionee's termination of service as a Board
member for any reason other than death. Should the optionee die
while serving as a Board member or during the six-month period
following his or her cessation of Board service, then such option
will remain exercisable for a 12-month period following such
optionee's death and may be exercised by the personal
representatives of the optionee's estate or the person to whom the
grant is transferred by the optionee's will or the laws of
inheritance. In no event, however, may the option be exercised
after the expiration date of the option term. During the
applicable exercise period, the option may not be exercised for
more than the number of shares (if any) in which the optionee is
vested at the time of his or her cessation of Board service.
- The option will become immediately exercisable for all of the
shares of Common Stock at the time subject to such option in the
event of a Corporate Transaction. Immediately following the
consummation of the Corporate Transaction, the option will
terminate, except to the extent assumed by the successor
corporation (or its parent company).
- The option will become immediately exercisable for all of the
shares of Common Stock at the time subject to such option in the
event of a Change in Control. A Change in Control will be deemed
to occur under the Restated Plan in the event (a) any person or
related group of persons (other than the Company or any affiliate)
acquires beneficial ownership of securities possessing more than
50% of the combined voting power of the Company's outstanding
securities pursuant to a tender or exchange offer which the Board
does not recommend the Company's stockholders to accept or (b)
there is a change in the composition of the Board over a period of
24 consecutive months or less such that a majority of the Board
members cease, by reason of one or more proxy contests for the
election of Board members, to be comprised of individuals who are
either (i) Board members who have served continuously during such
period (continuing Board members) or (ii) Board members who were
elected or nominated during such period by continuing Board
members.
7
10
- Each automatic option in effect for at least six months will
automatically be canceled upon the occurrence of a Hostile
Take-Over, and the optionee will in return be entitled to a cash
distribution from the Company in an amount equal to the excess of
(A) the Take-Over Price of the shares of Common Stock at the time
subject to the canceled option (whether or not the option is
otherwise at the time exercisable for such shares) over (B) the
aggregate exercise price payable for such shares.
- No automatic option will be granted if the Board member receives
an automatic grant under another of the Company's option plans.
- The remaining terms and conditions of the option grants under the
Automatic Option Grant Program will in general conform to the
terms described above for option grants made under the
Discretionary Option Grant Program and will be incorporated into
the option agreement evidencing the automatic grant.
Excess Grants
The Restated Plan permits the grant of options to purchase shares of
Common Stock in excess of the number of shares then available for issuance under
the Restated Plan. Any option so granted cannot be exercised prior to
stockholder approval of an amendment increasing the number of shares available
for issuance under the Restated Plan.
Changes in Capitalization
In the event any change is made to the Common Stock issuable under the
Restated Plan by reason of (a) a Corporate Transaction or (b) any stock split,
stock dividend, combination of shares, recapitalization or other similar change
in the corporate structure of the Company effected without receipt of
consideration, then unless such change results in the termination of all
outstanding options pursuant to the Corporate Transaction provisions of the
Restated Plan, appropriate adjustments will be made to (i) the maximum number
and/or class of securities available for issuance under the Restated Plan, (ii)
the maximum number and class of securities for which any one participant may be
granted stock options and separately exercisable stock appreciation rights under
the Restated Plan, (iii) the number and/or class of securities and price per
share in effect under each outstanding option under the Discretionary Option
Grant Program, (iv) the number and/or class of securities per non-employee Board
member for which automatic option grants are subsequently to be made under the
Automatic Option Grant Program, and (v) the number and/or class of securities
and price per share of the Common Stock in effect under each automatic grant
outstanding under the Automatic Option Grant Program. The purpose of such
adjustments to the outstanding options is to preclude the enlargement or
dilution of rights and benefits under such options.
8
11
Amendment and Termination of the Restated Plan
The Board may amend or modify the Restated Plan in any or all respects
whatsoever. However, the Board will not, without stockholder approval; increase
the maximum number of shares available for issuance under the Restated Plan
except in the event of certain changes to the Company's capitalization, and
certain other amendments may require stockholder approval pursuant to applicable
laws or regulations.
The Board may terminate the Restated Plan at any time, but in all events
the Restated Plan will terminate upon the earlier of March 12, 2011 or the date
all shares available for issuance under the Restated Plan are issued or canceled
pursuant to the exercise or surrender of options granted under the Restated
Plan. Any options outstanding at the time of the termination of the Restated
Plan will remain in force in accordance with the provisions of the instruments
evidencing such grants.
Federal Income Tax Consequences
Options granted under the Restated Plan may be either incentive stock
options which satisfy the requirements of Section 422 of the Internal Revenue
Code or non-statutory options which are not intended to meet such requirements.
The Federal income tax treatment for the two types of options differs as
follows:
Incentive Options. No taxable income is recognized by the optionee at the
time of the option grant, and no taxable income is generally recognized at the
time the option is exercised. The optionee will, however, recognize taxable
income in the year in which the purchased shares are sold or otherwise made the
subject of a taxable disposition. For Federal tax purposes, dispositions are
divided into two categories: (i) qualifying and (ii) disqualifying. A qualifying
disposition occurs if the sale or other disposition is made after the optionee
has held the shares for more than two years after the option grant date and more
than one year after the exercise date. If either of these two holding periods is
not satisfied, then a disqualifying disposition will result.
If the optionee makes a disqualifying disposition of the purchased
shares, then the Company will be entitled to an income tax deduction for the
taxable year in which such disposition occurs, equal to the excess of (i) the
fair market value of such shares on the option exercise date over (ii) the
exercise price paid for the shares. In no other instance will the Company be
allowed a deduction with respect to the optionee's disposition of the purchased
shares.
Non-Statutory Options. No taxable income is recognized by an optionee
upon the grant of a non-statutory option. The optionee will in general recognize
ordinary income, in the year in which the option is exercised, equal to the
excess of the fair market value of the purchased shares on the exercise date
over the exercise price paid for the shares, and the optionee will be required
to satisfy the tax withholding requirements applicable to such income.
9
12
If the shares acquired upon exercise of the non-statutory option are
unvested and subject to repurchase by the Company in the event of the optionee's
termination of service prior to vesting in those shares, then the optionee will
not recognize any taxable income at the time of exercise but will have to report
as ordinary income, as and when the Company's repurchase right lapses, an amount
equal to the excess of (i) the fair market value of the shares on the date the
repurchase right lapses over (ii) the exercise price paid for the shares. The
optionee may, however, elect under Section 83(b) of the Internal Revenue Code to
include as ordinary income in the year of exercise of the option an amount equal
to the excess of (i) the fair market value of the purchased shares on the
exercise date over (ii) the exercise price paid for such shares. If the Section
83(b) election is made, the optionee will not recognize any additional income as
and when the repurchase right lapses.
The Company will be entitled to an income tax deduction equal to the
amount of ordinary income recognized by the optionee with respect to the
exercised non-statutory option. The deduction will in general be allowed for the
taxable year of the Company in which such ordinary income is recognized by the
optionee.
Deductibility of Executive Compensation
The Company anticipates that any compensation deemed paid by it in
connection with disqualifying dispositions of incentive stock option shares or
exercises of non-statutory options granted with exercise prices equal to the
fair market value of the shares on the grant date will qualify as
performance-based compensation for purposes of Internal Revenue Code Section
162(m) and will not have to be taken into account for purposes of the $1.0
million limitation per covered individual on the deductibility of the
compensation paid to certain executive officers of the Company.
Accounting Treatment
Option grants or stock issuances with exercise or issue prices
less than the fair market value of the shares on the grant or issue date will
result in a deferred compensation expense equal to the difference between the
exercise or issue price and the fair market value of the shares on the grant or
issue date. Such expense will be recognized by the Company over the vesting
period of the options. Option grants or stock issuances at or above 100% of fair
market value will not result in any charge to the Company's earnings, but the
Company must disclose, on a pro-forma basis in the Notes to the Company's
financial statements, the impact those options would have upon the Company's
reported earnings were the value of those options determined using a fair-value
method. The number of outstanding options may be a factor in determining the
Company's earnings per share on a fully-diluted basis.
10
13
Should one or more optionees be granted stock appreciation rights
which have no conditions upon exercisability other than a service or employment
requirement, then such rights may be recognized as a compensation expense.
STOCK PURCHASE AGREEMENT
On May 10, 2001, the Company entered into a Memorandum of Understanding
Relating to Common Stock Issuance and Related Transactions (the "Investment
MOU") with the New Investor. The Company filed a copy of the Investment MOU as
Exhibit 99.1 to its report on Form 8-K dated May 15, 2001.
On June, 21, 2001, the Company's Board of Directors approved, subject to
stockholder approval, the Stock Purchase Agreement. On July 3, 2001, Teamasia
executed written consent approving the Stock Purchase Agreement. Pursuant to the
Investment MOU and the Stock Purchase Agreement, the Company will issue to the
New Investor an aggregate of 27,411,420 unregistered shares of Common Stock for
a purchase price of $6.0 million, or approximately $0.22 per share, in a private
placement. Members of the New Investor include Subba Rao Pinamaneni, the
Company's Chairman of the Board, Sugriva Reddy, the Company's Chief Executive
Officer, John Chu, the Company's Vice President and General Manager--Standard
Products, Moiz Khambaty, the Company's Vice President--Technology, Tarsaim
Batra--the Company's Chief Operating Officer and Vice President--Manufacturing,
K.Y. Mok, Dilip Kumor V. Lakhi and Sam Lee. As of the date of this Information
Statement, the New Investor had advanced the $6.0 million purchase price to the
Company, which the Company is using for working capital and other general
corporate purposes.
Also on May 10, 2001 and in connection with entering into the Investment
MOU, the Company entered into a Memorandum of Understanding Relating to
Amendment of Convertible Debentures and Support of Investment Transactions (the
"Amendment MOU") with Teamasia and one of its affiliates (together, the
"Teamasia Group"). The Company filed a copy of the Amendment MOU as Exhibit
99.2 to its report on Form 8-K dated May 15, 2001. Pursuant to the Amendment
MOU, the terms of $3.5 million of convertible debentures held by the Teamasia
Group, which otherwise would have become due and payable in May and June 2001,
were amended as follows: (1) the maturity date was extended for one year;
(2) interest will accrue at the prime rate and be payable on the maturity date;
and (3) the conversion rate was reduced from $1.75 to $0.69, the closing price
of the Company's Common Stock on May 10, 2001. The Amendment MOU also provides
that (i) the Company will issue a warrant to the Teamasia Group to purchase
approximately 1.6 million shares of Common Stock at an exercise price of $0.22
per share and (ii) the Teamasia Group will continue to be entitled to nominate
one director for election to the Company's Board of Directors for so long as
the Teamasia Group continues to own at least five percent of the outstanding
Common Stock.
Change In Control
11
14
Upon completion of the transactions contemplated by the Investment MOU
and the Amendment MOU, the New Investor will own approximately 72% of the
Common Stock, without giving effect to the exercise of outstanding options held
by employees or the conversion of the outstanding convertible debentures. As a
result, these transactions will constitute a change in control of the Company
and will dilute the equity interests of other holders of Common Stock.
The foregoing is a summary of the principal features of the Stock
Purchase Agreement and related transactions. Any stockholder of the company who
wishes to obtain a copy of the Investment MOU, the Amendment MOU or the Stock
Purchase Agreement may do so upon written request to the Secretary of the
Company at the Company's principal executive offices in San Jose, California.
RESTATED CERTIFICATE
Pursuant to the Restated Certificate, the Company will be authorized
to issue 21,000,000 shares of capital stock, of which 20,000,000 shall be Common
Stock and 1,000,000 of which shall be Preferred Stock. The Restated Certificate
will effect a 1-for-5 reverse stock split of the Common Stock (the "Reverse
Split") outstanding as of the close of business in Delaware on the record date.
Each share of Common Stock outstanding on the record date will be converted and
reconstituted into 1/5 of one share of Common Stock. Any fractional number of
shares remaining after applying the Reverse Split to each certificate
representing shares of Common Stock then held by any holder will be redeemed at
a purchase price equal to the closing bid price of the Common Stock on the
record date. Shares of Common Stock that were outstanding prior to the Reverse
Split, and that are not outstanding after and as a result of the Reverse Split,
shall resume the status of authorized but unissued shares of Common Stock.
The Company has determined to effect the Reverse Split to satisfy the
continuing listing requirements of Nasdaq. Nasdaq has notified the Company that
its stock price quoted on Nasdaq had fallen below the $1.00 per share minimum
required for listing on the Nasdaq trading system.
The foregoing is a summary of the principal features of the Restated
Certificate. Any stockholder of the company who wishes to obtain a copy of the
Restated Certificate may do so upon written request to the Secretary of the
Company at the Company's principal executive offices in San Jose, California.
STOCKHOLDER APPROVAL PREVIOUSLY GRANTED
Restated Plan
As of March 12, 2001, the Company had approximately 8,953,706 issued and
outstanding shares of Common Stock, each of which is entitled to one vote on any
matter brought to a vote of the Company's stockholders. On that date, Teamasia
owned 5,464,408 shares of Common Stock. Teamasia's share ownership represented
approximately 61% of all issued and outstanding shares of the Company's voting
stock. By written consent in lieu of a meeting, dated March 12, 2001, Teamasia
approved the adoption of the Restated Plan. Such action by written consent was
sufficient to satisfy the requirements for approval of the Restated Plan under
the
12
15
Delaware General Corporation Law. Accordingly, the stockholders will not be
asked to take further action on this corporate action at any future meeting.
However, since stockholder approval was obtained by written consent rather than
at a stockholders' meeting, the Exchange Act will not permit the action to
become effective until the expiration of 20 calendar days from the date this
Information Statement is being mailed to stockholders. Upon expiration of such
20-day period, the actions will become effective automatically.
Investment MOU and New Investor Stock Purchase Agreement
Stockholder approval of the Stock Purchase Agreement is not required by
the General Corporation Law of Delaware, the Company's Certificate of
Incorporation or the Company's Bylaws. Stockholder approval is required under
the Nasdaq rules, however, because the number of shares of Common Stock to be
issued by the Company to the New Investor pursuant to the Stock Purchase
Agreement represents more than 19.9% of the outstanding Common Stock.
Accordingly, by written consent in lieu of a meeting, dated as of July 3, 2001,
Teamasia approved the Stock Purchase Agreement and the transactions contemplated
thereby. As of that date, Teamasia owned 5,464,408 shares of Common Stock,
representing approximately 61% of the issued and outstanding shares of Common
Stock. Such action by written consent was sufficient to satisfy the requirements
for approval of the Stock Purchase Agreement under the Nasdaq rules. Therefore,
the stockholders will not be asked to take further action on this corporate
action at any future meeting. However, since stockholder approval was obtained
by written consent rather than at a stockholders' meeting, the Exchange Act will
not permit the action to become effective until the expiration of 20 calendar
days from the date this Information Statement is being mailed to stockholders.
Upon expiration of such 20-day period, the actions will become effective
automatically.
Restated Certificate
By written consent in lieu of a meeting, dated as of July 3, 2001,
Teamasia approved the adoption of the Restated Certificate. Such action by
written consent was sufficient to satisfy the requirements for approval of the
Restated Certificate under the Delaware General Corporation Law. Accordingly,
the stockholders will not be asked to take further action on this corporate
action at any future meeting. However, since stockholder approval was obtained
by written consent rather than at a stockholders' meeting, the Exchange Act will
not permit the action to become effective until the expiration of 20 calendar
days from the date this Information Statement is being mailed to stockholders.
Upon expiration of such 20-day period, the actions will become effective
automatically.
13
16
NO DISSENTERS RIGHTS
The corporate action described in this Information Statement will not
afford to stockholders the opportunity to dissent from the action described
herein or to receive an agreed or judicially appraised value for their shares of
Common Stock.
INTEREST OF CERTAIN PERSONS
The non-employee directors and executive officers of the Company may be
deemed to have a substantial interest in the approval of the Restated Plan
because they may be granted options to purchase shares of Common Stock pursuant
to the provisions of the Restated Plan. Non-employee directors will receive
formula grants pursuant to the Restated Plan's Automatic Option Grant Program.
Subba Rao Pinamaneni, Sugriva Reddy, John Chu, Moiz Khambaty, Tarsaim
Batra, K.Y. Mok, Dilip Kumor V. Lakhi and Sam Lee may be deemed to have a
substantial interest in the approval of the Stock Purchase Agreement and the
transactions contemplated therein because they are members of Subba Mok LLC, the
New Investor. Subba Rao Pinamaneni, as Managing Director and a stockholder of
Teamasia, and Sugriva Reddy, as Vice President of Teamasia, are also affiliates
of Teamasia. Marcus Thompson is the Chief Investment Officer of HSBC Private
Equity (Asia) Limited, an affiliate of Teamasia.
SHARE OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth certain information known to the Company
regarding the ownership of the Common Stock as of March 31, 2001 for (a) each
director, (b) all persons who are beneficial owners of five percent or more of
the Common Stock, (c) the Company's Chief Executive Officer and the four other
most highly-compensated executive officers of the Company for services rendered
in all capacities to the Company and its subsidiaries (the "Named Executive
Officers") and (d) all current directors and officers as a group. Unless
otherwise
14
17
indicated, each of the stockholders has sole voting and investment power with
respect to the shares of Common Stock beneficially owned, subject to community
property laws, where applicable.
Percent of Total
Name Number of Shares Shares Outstanding (1)
-------------------------------- ---------------- ----------------------
Teamasia Semiconductors PTE Ltd. 671,173 61%
Sugriva Reddy -- *
Brad Whitney (2) 1,000 *
Ralph Brandi -- *
A S T Rajan -- *
Marcus Thompson -- *
Moiz Khambaty 7,167 *
Tarsaim Batra 9,499 *
John Chu -- *
Subbarao Pinamaneni (3) -- *
All current directors and
officers as a group 17,666 *
(1) Percentage of beneficial ownership is calculated assuming 8,953,706
shares of Common Stock were outstanding on March 31, 2001. This
percentage may include Common Stock which such individual or entity has
the right to acquire beneficial ownership of within 60 days of March 31,
2001, including but not limited to the exercise of an option, provided,
however, that such shares are not deemed outstanding for the purpose of
computing the percentage ownership owned by any other person. Such
calculation is required by General Rule 13d-3(d)(1)(i) under the Exchange
Act.
(2) As of July 18, 2000, Mr. Whitney is no longer an officer of the Company.
Shares beneficially owned by Mr. Whitney are in the name of Brad and Gail
Whitney.
(3) Mr. Pinamaneni is a Managing Director and stockholder of Teamasia Pte
Ltd. Mr. Pinamaneni disclaims beneficial ownership of the Company's
Common Stock owned by Teamasia Semiconductors PTE Ltd. (except to extent
of his beneficial ownership therein).
15
18
Summary Compensation Table
The following table provides certain summary information concerning the
compensation earned by the Named Executive Officers during each of the last
three years.
Long Term
Securities Other
Salary Underlying Bonus Other Compensation
Name and Position Year ($) (1) ($) Options ($) (2)
-------------------------------------- ------ ------- ---------------- --------- ------------
Subbarao Pinamaneni, 2001 200,000(3) -- -- --
Chairman 2000 -- -- -- --
1999 -- -- -- --
Sugriva Reddy, Acting President, 2001 $51,682 -- -- --
Chief Executive Officer and Director 2000 80,733 -- -- --
1999 -- -- -- --
Brad Whitney, former President and 2001 -- -- -- --
Chief Executive Officer 2000 112,000 -- -- --
1999 -- -- -- --
Tarsaim Batra, Vice President, 2001 51,386 -- -- 3,000
Manufacturing and Chief Operating 2000 144,942 -- 30,000 6,984
Officer 1999 132,126 -- -- 6,636
Moiz Khambaty, Vice President, 2001 45,267 -- -- --
Technology 2000 147,490 -- 25,000 9,320
1999 146,480 -- -- 9,192
Ron Laugesen, Vice President, 2001 34,849 -- -- --
Product Engineering 2000 135,291 -- 20,000 3,984
1999 137,388 -- -- 3,636
John Chu, Vice President, Design 2001 49,259 -- -- --
Engineering 2000 -- -- -- --
1999 -- -- -- --
(1) Salary includes amounts deferred pursuant to the Company's 401(k) plan.
The amounts shown under the Bonus column include cash bonuses earned for
the indicated fiscal years.
18
19
(2) Includes the premium paid on behalf of each executive officer for
supplemental life insurance plus any other amount as indicated for each
individual.
Stock Option Grants in Fiscal Year ending March 31, 2001
The following tables show, for the fiscal year ending March 31, 2001,
information regarding options granted to the Named Executive Officers.
The exercise price of the option granted to John Chu was equal to the
fair value of the Company's Common Stock as valued by the Board of Directors on
the date of grant.
The potential realizable value is calculated based on the 10 year term
of the option at the time of grant. Stock price appreciation of 5 percent and 10
percent is assumed pursuant to rules promulgated by the Securities and Exchange
Commission and does not represent our prediction of the Company's stock price
performance. The potential realizable values at 5 percent and 10 percent
appreciation are calculated by:
- multiplying the number of shares of Common Stock subject to a given
option by the exercise price per share;
- assuming that the aggregate stock value derived from that
calculation compounds at the annual 5 percent or 10 percent rate
shown in the table until the expiration of the options; and
- subtracting from that result the aggregate option exercise price.
The shares listed in the following table under "Number of Securities
Underlying Options Granted" vest at the rate of 25% annually, and the option
granted to John Chu has a 10 year term, subject to earlier termination if the
optionee's service with the Company ceases.
Percentages shown under "Percent of Total Options Granted to Employees
in Fiscal Year" are based on options for the purchase of 2,158,927 shares of the
Company's Common Stock granted to our employees during the fiscal year ending
March 31, 2001.
Potential Realizable Value At
Assumed Annual Rates Of
Stock Price Appreciation For
Individual Grants Option Term
-------------------------------------------------- -----------------------------
Percent of
Number of Total
Securities Options
Underlying Granted To Exercise Of
Options Employees In Base Price
Name Granted (#) Fiscal Year ($/share) Expiration Date 5%($) 10%($)
---- ------------ ------------ ----------- --------------- ------------- ------------
Subbarao Pinamaneni -- -- -- -- -- --
Sugriva Reddy -- -- -- -- -- --
Taraim Batra -- -- -- -- -- --
Moiz Khambaty -- -- -- -- -- --
Ron Laugesen -- -- -- -- -- --
John Chu 300,000 13.9% $1.96 March 14, 2011 $369,790.04 $937,120.57
Option Exercises and Holdings
No Named Executive Officer exercised any stock options during the
fiscal year ending March 31, 2001.
19
20
This Section is not "Soliciting Material," is not deemed filed with the
SEC and is not to be incorporated by reference in any filing of the Company
under the Securities Act or the Exchange Act.
DELIVERY OF DOCUMENTS TO SECURITY HOLDERS SHARING AN ADDRESS
Only one Information Statement is being delivered to multiple
stockholders sharing an address unless the Company has received contrary
instructions from one or more of the stockholders. The Company undertakes to
deliver promptly, upon written or oral request, a separate copy of the
Information Statement to a stockholder at a shared address to which a single
copy of the Information Statement was delivered and provide instructions as to
how a stockholder can notify the Company that the stockholder wishes to receive
a separate copy of an Information Statement. A stockholder can request a
separate copy of the Information Statement by telephoning the Company at (408)
432-9100 or by sending a written request to IMP, Inc., ATTN: Investor Relations,
2830 North First Street, San Jose, CA 95134. A stockholder can also request to
receive a separate annual report or proxy statement, as applicable, in the
future, or, alternatively, request delivery of a single copy of annual reports
or information statements if stockholders sharing an address are receiving
multiple copies of annual reports or information statements.
20
21
Pursuant to the requirements of the Exchange Act, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto
authorized.
IMP, Inc.
Date: August 21, 2001 By: /s/ Subba Rao Pinamaneni
---------------------------------------
Name: Subba Rao Pinamaneni
Title: Chairman of the Board of Directors
21